NEW & NOTABLE
CT bioscience environment attracts Boehringer Ingelheim expansion
CI makes $250,000 follow-on investment in Innovatient Solutions
Jackson Lab CEO leads lively panel discussion
Ce3 CEO Holly Coulter to present at clinical research forum
Rib-X Pharmaceuticals initiates delafloxacin global Phase 3 trial
Rib-X Pharmaceuticals appoints John E. Sununu to Board of Directors
CURE's Peter Farina: Why ‘Next Generation Connecticut’ makes sense
Protein Sciences ready to make vaccine for H7N9 influenza virus
Penner's New Haven Pharmaceuticals wins $2 million in financing
Talent from 454 Life Sciences

WHY CONNECTICUT?
Connecticut's strategic location within the East Coast healthcare corridor is your competitive advantage.
Learn More

STEM CELL RESEARCH
Connecticut's stem cell law established state funding of $100 million for stem cell research. The measure catapaulted Connecticut into the vanguard of states that are taking active steps to encourage research in what many see as one of the most important avenues for bioscience investment. Learn More